For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS
Source: Variant News  May 03, 2021  3 years, 7 months, 3 hours, 47 minutes ago

Study Warns That SARS-Cov-2 Is Developing Membrane Gene Mutations Such As M:182T, Making It More Transmissible Among The Younger!

Study Warns That SARS-Cov-2 Is Developing Membrane Gene Mutations Such As M:182T, Making It More Transmissible Among The Younger!
Source: Variant News  May 03, 2021  3 years, 7 months, 3 hours, 47 minutes ago
Variant News: A new study by researchers from the Keck School of Medicine at the University of Southern California has highlighted the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant with mutations in the membrane protein-encoding gene. Two potential mutations, M:I82T and M:V70L, have been identified within the transmembrane helices, which are expected to improve viral fitness by modulating glucose uptake during replication.


 
To date, mutations in the SARS-CoV-2 Membrane (M) gene are relatively uncommon. The M gene encodes the most abundant viral structural protein, and is implicated in multiple viral functions, including initial attachment to the host cell via heparin sulfate proteoglycan, viral protein assembly in conjunction with the N and E genes, and enhanced glucose transport.
 
Alarmingly the study team has identified a recent spike in the frequency of reported SARS-CoV-2 genomes carrying M gene mutations. This is associated with emergence of a new sub-B.1 clade, B.1.I82T, defined by the previously unreported M:I82T mutation within TM3, the third of three membrane spanning helices implicated in glucose transport. The frequency of this mutation increased in the USA from 0.014% in October 2020 to 1.62% in February 2021, a 116-fold change.
 
While constituting 0.7% of the isolates overall, M:I82T sub-B.1 lineage accounted for 14.4% of B.1 lineage isolates in February 2021, similar to the rapid initial increase previously seen with the B.1.1.7 and B.1.429 lineages, which quickly became the dominant lineages in Europe and California over a period of several months. A similar increase in incidence was also noted in another related mutation, V70L, also within the TM2 transmembrane helix.
 
Interestingly these M mutations are associated with younger patient age (4.6 to 6.3 years). The rapid emergence of this B.1.I82T clade suggests that this M gene mutation is more biologically fit, perhaps related to glucose uptake during viral replication, and should be included in ongoing genomic surveillance efforts and warrants further evaluation for potentially increased pathogenic and therapeutic implications.
 
The study findings were published were published in the peer reviewed journal:  Emerging Microbes and Infections.
https://www.tandfonline.com/doi/full/10.1080/22221751.2021.1922097


Phylogenetic analysis of viral genomes carrying missense M mutations, colored by lineage background.

The whole-genome sequencing studies of newly emerging viral variants are particularly important for identifying mutations that emerge under positive selection and play vital roles in viral evolution.
 
It was found that in the later phase of the coronavirus disease 2019 (COVID-19) pandemic, several novel SARS-CoV-2 variants with multiple spike protein mutations have emerged. Because of significantly increased infectivity and immune escape ability, some of these variants have become the predominantly circulating v ariants worldwide. Therefore, to effectively control the trajectory of COVID-19 pandemic, continuous genomic surveillance of SARS-CoV-2 sequences both at the national- and global level are of prime importance.
 
For the study, the research team reported the emergence of a novel SARS-CoV-2 variant containing signature mutations in the membrane protein-encoding gene.
 
The study team conducted reverse transcription-polymerase chain reaction (RT-PCR) for whole-genome sequencing of a total of 2,900 SARS-CoV-2-positive patient samples.
 
The team subsequently compared these sequences with full-length SARS-CoV-2 sequences downloaded from the GISAID and NCBI databases for viral variant analysis.
 
Also the researchers performed phylogenetic analysis and SARS-CoV-2 membrane protein structural predictions using a multiple sequence alignment program and a specialized service for structural analysis of missense variants.      
 
By detailed analysis of the missense mutation carrying genome and synonymous mutation carrying genome, the study team estimated that missense mutations should occur 2.7 times, 3.1 times, 3.8 times more frequently than the synonymous mutations in the envelope protein-coding gene, membrane protein-coding gene, and ORF6-coding gene, respectively. By comparing missense mutation carrying genomes with synonymous mutation carrying genomes, they noticed that the membrane gene is highly conserved and possibly under robust purifying selection.
 
Furthermore by estimating the membrane gene missense mutation carrying viral genomes, they identified only 4 missense mutations in viral genomes collected from the USA in February 2021. With further analysis, they observed a gradual increase in missense membrane gene mutations in viral genomes in the USA and worldwide.
 
Detailed analysis of the frequency of increase for these mutations lead the study team to discover that M:I48V mutation is highly specific to the USA and that most of the viral isolates carrying this mutation belong to the B.1.375 lineage. However, currently, the frequency of this mutation dropped significantly in the USA.     
 
However in contrast to the M:I48V mutation, the frequency of M:I82T mutation was found to increase by 116-fold between October 2020 and February 2021 in the USA.
 
The study team confirmed that the viral isolates carrying this mutation predominantly belong to the B.1 and B.1.525 lineages and that about 99% of the B.1.525 lineage currently carry this mutation.
 
Following further analysis, the scientists noticed that the largest M:I82T carrying clade is part of a young M:I82T sub-B.1 lineage and that about 90% of the isolates in this clade contain 10 other missense mutations.
 
They mentioned that the M:I82T clade is significantly different from other B.1 lineage clades, and thus, a separate designation is required for this clade. Interestingly, they found that the second-largest M:I82T carrying clade is currently circulating in Europe and Africa and co-segregating with the E484K Spike protein mutation. Because of the absence of E484K Spike mutation in the USA M:I82T clade, the scientists suggest that M:I82T mutation may have implications in viral evolution independent of E484K Spike mutation.    
      
The study team identified a number of other membrane gene mutations that showed a recent surge in frequency worldwide. Focusing on these mutations, they collected more than 5,500 sequences carrying any of these mutations for phylogenetic analysis. Their analysis revealed that many of these sequences belong to the B.1.1.7 lineage, which also carries a synonymous membrane gene mutation.
 
Also the team selected four membrane gene mutations (M:A2S, M:F28L, M:I82T, and M:V70L) and analyzed their presence in viral isolates collected from the study patients. Their analysis revealed that the mean age of patients carrying each of these mutations was 37 – 39 years, whereas the mean age of patients without these mutations was 43 years.
 
The research findings highlights the rapid emergence of the B.1.I82T clade with SARS-CoV-2 membrane gene mutations in the USA and worldwide.
 
Overall, the findings suggest that viral variants containing membrane gene mutations exhibit higher transmissibility among younger populations and that mutations emerging in the viral membrane protein-encoding gene play crucial roles in increasing viral fitness probably by controlling glucose uptake during viral replication.
 
For the latest Variant News, keep on logging to Thailand Medical News.
 

MOST READ

Nov 05, 2024  28 days ago
Nikhil Prasad
Nov 05, 2024  28 days ago
Nikhil Prasad
Jul 25, 2024  4 months ago
Nikhil Prasad
Jul 24, 2024  4 months ago
Nikhil Prasad